Literature DB >> 15668232

A second human Dbf4/ASK-related protein, Drf1/ASKL1, is required for efficient progression of S and M phases.

Naoko Yoshizawa-Sugata1, Ai Ishii, Chika Taniyama, Etsuko Matsui, Ken-ichi Arai, Hisao Masai.   

Abstract

Cdc7-Dbf4 kinase is conserved through evolution and regulates initiation and progression of DNA replication. In human, ASK/hsDbf4 binds and activates huCdc7 during S phase and this kinase complex is essential for DNA replication and cell proliferation. Drf1/ASKL1, a second human Dbf4/ASK-related protein, shares three conserved Dbf4 motifs previously identified on all of the Dbf4-related molecules. Drf1/ASKL1 can bind and activate huCdc7, and Cdc7-ASKL1 complex phosphorylates MCM2. ASKL1 transcription and protein levels oscillate during cell cycle and increase at late S to G2/M phases. The protein is detected predominantly in the nuclear-soluble fraction but not in the chromatin-bound fraction. Inhibition of Drf1/ASKL1 expression by siRNA results in attenuation of cell growth and in the increase of late S and G2/M phase population. siRNA treatment on synchronized cell population revealed that S phase progression is delayed when ASKL1 protein level is decreased. S phase delay may be linked to replication fork block, because increased levels of gammaH2AX and activated form of Chk2 are detected with ASKL1 siRNA in the absence of any additional DNA damages. Furthermore, mitotic progression is retarded in ASKL1 or Cdc7 siRNA-treated cells. Our results suggest that ASKL1 in a complex with Cdc7 may play a role in normal progression of both S and M phases.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15668232     DOI: 10.1074/jbc.M411653200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  25 in total

1.  Cdc7-Drf1 is a developmentally regulated protein kinase required for the initiation of vertebrate DNA replication.

Authors:  Tatsuro S Takahashi; Johannes C Walter
Journal:  Genes Dev       Date:  2005-10-01       Impact factor: 11.361

Review 2.  Integrating S-phase checkpoint signaling with trans-lesion synthesis of bulky DNA adducts.

Authors:  Laura R Barkley; Haruo Ohmori; Cyrus Vaziri
Journal:  Cell Biochem Biophys       Date:  2007       Impact factor: 2.194

3.  Cdc7-Drf1 kinase links chromosome cohesion to the initiation of DNA replication in Xenopus egg extracts.

Authors:  Tatsuro S Takahashi; Abhijit Basu; Vladimir Bermudez; Jerard Hurwitz; Johannes C Walter
Journal:  Genes Dev       Date:  2008-07-15       Impact factor: 11.361

4.  Transcriptional co-activator LEDGF interacts with Cdc7-activator of S-phase kinase (ASK) and stimulates its enzymatic activity.

Authors:  Siobhan Hughes; Victoria Jenkins; Mohd Jamal Dar; Alan Engelman; Peter Cherepanov
Journal:  J Biol Chem       Date:  2009-10-28       Impact factor: 5.157

Review 5.  Dbf4: the whole is greater than the sum of its parts.

Authors:  Lindsay A Matthews; Alba Guarné
Journal:  Cell Cycle       Date:  2013-04-02       Impact factor: 4.534

6.  3D Pharmacophore Model-Assisted Discovery of Novel CDC7 Inhibitors.

Authors:  Mika Lindvall; Christopher McBride; Maureen McKenna; Thomas G Gesner; Asha Yabannavar; Kent Wong; Song Lin; Annette Walter; Cynthia M Shafer
Journal:  ACS Med Chem Lett       Date:  2011-08-02       Impact factor: 4.345

Review 7.  Regulation of the initiation of DNA replication in human cells.

Authors:  Tatiana N Moiseeva; Christopher J Bakkenist
Journal:  DNA Repair (Amst)       Date:  2018-09-12

8.  Characterization of a Drosophila ortholog of the Cdc7 kinase: a role for Cdc7 in endoreplication independent of Chiffon.

Authors:  Robert Stephenson; Marcus R Hosler; Navnath S Gavande; Arun K Ghosh; Vikki M Weake
Journal:  J Biol Chem       Date:  2014-12-01       Impact factor: 5.157

9.  The vaccinia-related kinases phosphorylate the N' terminus of BAF, regulating its interaction with DNA and its retention in the nucleus.

Authors:  R Jeremy Nichols; Matthew S Wiebe; Paula Traktman
Journal:  Mol Biol Cell       Date:  2006-02-22       Impact factor: 4.138

10.  Drug design with Cdc7 kinase: a potential novel cancer therapy target.

Authors:  Masaaki Sawa; Hisao Masai
Journal:  Drug Des Devel Ther       Date:  2009-02-06       Impact factor: 4.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.